+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • October 2026
  • Region: Global
  • Grand View Research
  • ID: 5397831
The global point-of-care glucose testing market size was valued at USD 3.9 billion in 2025 and is projected to grow from USD 4.1 billion in 2026 to USD 5.7 billion by 2033, at a CAGR of 4.7 % from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.2% in 2025. The market is an established segment of the broader point-of-care diagnostics and blood glucose monitoring industry, supported by the need for rapid glucose measurement close to the patient.

POC glucose testing is primarily used in hospitals, emergency departments, physician offices, clinics, long-term care facilities, and other professional healthcare settings where immediate glucose results can support treatment decisions. The market mainly includes handheld blood glucose meters, compatible test strips, blood-sampling accessories, quality-control solutions, and connected data-management technologies. A key factor supporting demand is the continued clinical requirement for rapid glucose measurement in hospital settings, particularly for patients requiring close glycemic monitoring. POC glucose testing allows results to be generated without sending blood samples to a central laboratory, supporting faster clinical intervention.

The market is therefore driven by the need for rapid turnaround, bedside accessibility, repeated glucose measurements, and decentralized testing workflows across inpatient departments and other professional care environments. The FDA's POC-specific guidance requires manufacturers to demonstrate appropriate analytical and clinical performance for prescription-use systems, reflecting the importance of reliable glucose results when these devices are used for clinical decision-making.

Technological innovation and connectivity are increasingly important growth factors within the POC glucose testing market. Manufacturers are developing systems with barcode-based patient identification, wireless connectivity, automated data transfer, quality-control management, and integration with hospital information systems and digital POC-management platforms. Roche's hospital POC portfolio, for example, includes the Accu-Chek Inform II and cobas pulse systems, with the company highlighting connectivity with existing hospital infrastructure and integration with its navify POC digital solutions to support reporting, compliance, and workflow management. These capabilities are particularly relevant in hospitals with large numbers of meters and testing personnel, where automated patient identification and electronic result transmission can reduce manual data-entry requirements.

Recent regulatory activity also demonstrates continued product development specifically within professional POC glucose testing. For instance, in June 2026, the FDA cleared Roche Diagnostics' cobas pulse blood glucose monitoring system through the 510(k) pathway as a prescription-use blood glucose meter for near-patient testing. The FDA record identifies the device under product code PZI and confirms that the submission was determined to be substantially equivalent to legally marketed predicate devices. In addition, the FDA granted a CLIA waiver to the cobas pulse system on June, 2026, further supporting its use in applicable lower-complexity testing environments. The FDA's CLIA database also records the earlier February 2024 CLIA waiver of Nova Biomedical's StatStrip Glucose Hospital Meter System, demonstrating continued regulatory activity around professional POC glucose systems.

At the same time, accuracy, patient identification, quality control, and data-management requirements remain important considerations for market participants. A recent FDA recall provides a directly relevant example: on September 2026, the FDA classified a Class I recall of Nova Biomedical's StatStrip Glucose Hospital Meter System MultiPack after identifying a software synchronization issue that could cause a previously scanned patient barcode to remain displayed, potentially resulting in a glucose result being assigned to the wrong patient's medical record. The issue did not affect the analytical accuracy of the glucose measurement, but it highlighted the importance of correct patient identification and data transmission within hospital POC glucose workflows.

Global Point-of-Care Glucose Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global point-of-care glucose testing market report based on product, end use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Professional POC Testing
  • Handheld Glucose Meters
  • Benchtop/Desktop Glucose Analyzers
  • Multiparameter POC Analyzers
  • Test Strips
  • Cartridges
  • Reagents & Controls
  • Lancets & Other Consumables
  • Home-use/Self Testing
  • Blood Glucose Meters
  • Test Strips
  • Lancets & Lancing Devices
  • Other Accessories & Consumables

End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Institutional Channels
  • Hospitals and Clinics
  • Outpatient Facilities/Ambulatory Centers
  • Long-term Care Facilities
  • Home-care Settings

Region Outlook (Revenue, USD Million, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • Thailand
  • Australia
  • India
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. The internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. End Use Outlook
2.2.3. Regional Outlook
2.3. Competitive Insights
Chapter 3. Point-of-Care Glucose Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Point-of-Care Glucose Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Point-of-Care Glucose Testing Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Point-of-Care Glucose Testing Market: Product Movement Analysis
4.3. Point-of-Care Glucose Testing Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Professional POC Testing
4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Handheld Glucose Meters
4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Benchtop/Desktop Glucose Analyzers
4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Multiparameter POC Analyzers
4.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.5. Test Strips
4.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.6. Cartridges
4.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.7. Reagents & Controls
4.5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.8. Lancets & Other Consumables
4.5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Home-use/Self Testing
4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Blood Glucose Meters
4.6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. Test Strips
4.6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.4. Lancets & Lancing Devices
4.6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.5. Other Accessories & Consumables
4.6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Point-of-Care Glucose Testing Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Point-of-Care Glucose Testing Market: End Use Movement Analysis
5.3. Point-of-Care Glucose Testing Market by End Use Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Institutional Channels
5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.2. Hospitals and Clinics
5.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.3. Outpatient Facilities/Ambulatory Centers
5.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.4. Long-term Care Facilities
5.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Home-care Settings
5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Point-of-Care Glucose Testing Market: Regional Estimates & Trend Analysis
6.1. Regional Dashboard
6.2. Regional Point-of-Care Glucose Testing Market Movement Analysis
6.3. Point-of-Care Glucose Testing Market: Regional Estimates & Trend Analysis by Product & End Use
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. North America
6.5.1. North America Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. U.S.
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement scenario
6.5.2.5. U.S. Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Canada
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement scenario
6.5.3.5. Canada Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement scenario
6.5.4.5. Mexico Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.5. Europe
6.5.6. Europe Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.7. UK
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement scenario
6.5.7.5. UK Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.8. Germany
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement scenario
6.5.8.5. Germany Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.9. France
6.5.9.1. Key Country Dynamics
6.5.9.2. Competitive Scenario
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement scenario
6.5.9.5. France Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.10. Italy
6.5.10.1. Key Country Dynamics
6.5.10.2. Competitive Scenario
6.5.10.3. Regulatory Framework
6.5.10.4. Reimbursement scenario
6.5.10.5. Italy Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.11. Spain
6.5.11.1. Key Country Dynamics
6.5.11.2. Competitive Scenario
6.5.11.3. Regulatory Framework
6.5.11.4. Reimbursement scenario
6.5.11.5. Spain Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.12. Denmark
6.5.12.1. Key Country Dynamics
6.5.12.2. Competitive Scenario
6.5.12.3. Regulatory Framework
6.5.12.4. Reimbursement scenario
6.5.12.5. Denmark Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.13. Sweden
6.5.13.1. Key Country Dynamics
6.5.13.2. Competitive Scenario
6.5.13.3. Regulatory Framework
6.5.13.4. Reimbursement scenario
6.5.13.5. Sweden Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.14. Norway
6.5.14.1. Key Country Dynamics
6.5.14.2. Competitive Scenario
6.5.14.3. Regulatory Framework
6.5.14.4. Reimbursement scenario
6.5.14.5. Norway Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement scenario
6.6.2.5. Japan Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement scenario
6.6.3.5. China Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement scenario
6.6.4.5. India Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement scenario
6.6.5.5. South Korea Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement scenario
6.6.6.5. Australia Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement scenario
6.6.7.5. Thailand Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Latin America
6.7.1. Latin America Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Brazil Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement scenario
6.7.3.5. Argentina Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Middle East & Africa
6.8.1. Middle East & Africa Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement scenario
6.8.2.5. South Africa Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement scenario
6.8.3.5. Saudi Arabia Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement scenario
6.8.4.5. UAE Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Kuwait Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Key Company Profiles
7.2.1. F. Hoffmann-La Roche Ltd.
7.2.1.1. Company Overview
7.2.1.2. Financial Performance
7.2.1.3. Product Benchmarking
7.2.1.4. Strategic Initiatives
7.2.2. Abbott
7.2.2.1. Company Overview
7.2.2.2. Financial Performance
7.2.2.3. Product Benchmarking
7.2.2.4. Strategic Initiatives
7.2.3. Nova Biomedical
7.2.3.1. Company Overview
7.2.3.2. Financial Performance
7.2.3.3. Product Benchmarking
7.2.3.4. Strategic Initiatives
7.2.4. LifeScan IP Holdings, LLC
7.2.4.1. Company Overview
7.2.4.2. Financial Performance
7.2.4.3. Product Benchmarking
7.2.4.4. Strategic Initiatives
7.2.5. Ascensia Diabetes Care Holdings AG
7.2.5.1. Company Overview
7.2.5.2. Financial Performance
7.2.5.3. Product Benchmarking
7.2.5.4. Strategic Initiatives
7.2.6. Trividia Health, Inc.
7.2.6.1. Company Overview
7.2.6.2. Financial Performance
7.2.6.3. Product Benchmarking
7.2.6.4. Strategic Initiatives
7.2.7. EKF Diagnostics Holdings plc
7.2.7.1. Company Overview
7.2.7.2. Financial Performance
7.2.7.3. Product Benchmarking
7.2.7.4. Strategic Initiatives
7.2.8. ARKRAY, Inc.
7.2.8.1. Company Overview
7.2.8.2. Financial Performance
7.2.8.3. Product Benchmarking
7.2.8.4. Strategic Initiatives
7.2.9. A. Menarini Diagnostics S.r.l.
7.2.9.1. Company Overview
7.2.9.2. Financial Performance
7.2.9.3. Product Benchmarking
7.2.9.4. Strategic Initiatives
7.2.10. AgaMatrix, Inc.
7.2.10.1. Company Overview
7.2.10.2. Financial Performance
7.2.10.3. Product Benchmarking
7.2.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 4 Global Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 5 North America Point-of-Care Glucose Testing Market, Country, 2021 - 2033 (USD Million)
Table 6 North America Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 7 North America Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 8 U.S. Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 9 U.S. Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 10 Canada Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 11 Canada Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 12 Mexico Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 13 Mexico Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 14 Europe Point-of-Care Glucose Testing Market, Country, 2021 - 2033 (USD Million)
Table 15 Europe Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 16 Europe Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 17 UK Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 18 UK Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 19 Germany Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 20 Germany Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 21 France Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 22 France Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 23 Italy Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 24 Italy Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 25 Spain Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 26 Spain Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 27 Norway Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 28 Norway Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 29 Denmark Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 30 Denmark Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 31 Sweden Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 32 Sweden Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 33 Asia Pacific Point-of-Care Glucose Testing Market, Country, 2021 - 2033 (USD Million)
Table 34 Asia Pacific Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 35 Asia Pacific Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 36 China Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 37 China Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 38 Japan Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 39 Japan Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 40 South Korea Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 41 South Korea Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 42 Thailand Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 43 Thailand Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 44 Australia Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 45 Australia Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 46 India Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 47 India Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 48 Latin America Point-of-Care Glucose Testing Market, Country, 2021 - 2033 (USD Million)
Table 49 Latin America Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 50 Latin America Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 51 Brazil Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 52 Brazil Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 53 Argentina Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 54 Argentina Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 55 Middle East & Africa Point-of-Care Glucose Testing Market, Country, 2021 - 2033 (USD Million)
Table 56 Middle East & Africa Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 57 Middle East & Africa Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 58 South Africa Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 59 South Africa Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 60 Saudi Arabia Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 61 Saudi Arabia Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 62 UAE Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 63 UAE Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 64 Kuwait Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 65 Kuwait Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
List of Figures
Fig 1. Information procurement
Fig 2. Primary research pattern
Fig 3. Market research approaches
Fig 4. Value chain-based sizing & forecasting
Fig 5. Market formulation & validation
Fig 6. Point-of-care glucose testing market segmentation
Fig 7. Market driver analysis (Current & future impact)
Fig 8. Market restraint analysis (Current & future impact)
Fig 9. SWOT Analysis, Factor (Political & Legal, Economic and Technological)
Fig 10. Porter’s Five Forces Analysis
Fig 11. Point-of-care glucose testing market, product outlook key takeaways (USD Million)
Fig 12. Point-of-care glucose testing market: product movement analysis (USD Million), 2025 & 2033
Fig 13. Professional POC testing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 14. Handheld glucose meters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 15. Benchtop/desktop glucose analyzers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 16. Multiparameter POC analyzers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 17. Test strips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 18. Cartridges market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 19. Reagents & controls market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 20. Lancets & other consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 21. Home-use/self testing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 22. Blood glucose meters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 23. Test strips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 24. Lancets & lancing devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 25. Other accessories & consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 26. Point-of-care glucose testing market, end use outlook key takeaways (USD Million)
Fig 27. Point-of-care glucose testing market: end use movement analysis (USD Million), 2025 & 2033
Fig 28. Institutional channels market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 29. Hospitals and clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 30. Outpatient facilities/ambulatory centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 31. Long-term care facilities market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 32. Home-care settings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 33. Point-of-care glucose testing market, regional key takeaways (USD Million)
Fig 34. Point-of-care glucose testing market regional outlook, 2025 & 2033, USD Million
Fig 35. North America point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 36. U.S. point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 37. Canada point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 38. Mexico point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 39. Europe point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 40. UK point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 41. Germany point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 42. France point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 43. Italy point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 44. Spain point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 45. Denmark point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 46. Sweden point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 47. Norway point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 48. Asia Pacific point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 49. Japan point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 50. China point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 51. India point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 52. Australia point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 53. South Korea point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 54. Thailand point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 55. Latin America point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 56. Brazil point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 57. Argentina point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 58. Middle East & Africa point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 59. South Africa point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 60. Saudi Arabia point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 61. UAE point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 62. Kuwait point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 63. List of key emerging company’s/indication disruptors/innovators

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Nova Biomedical
  • LifeScan IP Holdings, LLC
  • Ascensia Diabetes Care Holdings AG
  • Trividia Health, Inc.
  • EKF Diagnostics Holdings plc
  • ARKRAY, Inc.
  • A. Menarini Diagnostics S.r.l.
  • AgaMatrix, Inc.